Pharmacotherapy for Anxiety and Comorbid Alcohol Use Disorders

About this resource:

Systematic Review

Source: The Cochrane Collaborative

Last Reviewed: January 2015

In this Cochrane systematic review, the Cochrane Collaborative found insufficient evidence to determine if certain medicines are effective in treating people with anxiety disorders and alcohol use problems. The studies included in the review assessed the effectiveness of selective serotonin reuptake inhibitors and buspirone, a 5‐hydroxytryptamine partial agonist. Researchers found that the quality of the evidence was very low, and side effects like sexual problems were commonly reported.

Read more about this resource

Objectives related to this resource (1)

Suggested Citation


Ipser, J.C., Wilson, D., Akindipe, T.O., Sager, C. & Stein, D.J. (2015). Pharmacotherapy for anxiety and comorbid alcohol use disorders. Cochrane Database of Systematic Reviews, 2015 (1). DOI: 10.1002/14651858.CD007505.pub2.